The prognostic value of occult peritoneal tumor cells, detected by ddPCR for KRAS, in patients with (borderline) resectable pancreatic cancer

The prognostic value of occult peritoneal tumor cells, detected by ddPCR for KRAS, in patients with (borderline) resectable pancreatic cancer - EXPECT study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51142

Enrollment

Registered

2021-07-30

Start date

2021-09-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastases pancreatic cancer

Interventions

None listed

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Indication for laparascopic cholecystectomy - Age > 18

Exclusion criteria

Exclusion criteria: A medical history of cancer

Design outcomes

Primary

Measure	Time frame
Presence or absence of KRAS mutation in peritoneal fluid.	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results